Consultant Cardiologist Oxford
Professor Adrian Banning is a Consultant Cardiologist specialising in valve and coronary intervention.
Professor Banning is one of the leading interventional Cardiologists in the UK with a worldwide reputation for clinical practice and research excellence He is senior interventional cardiologist in Oxford where has practiced since 1995.
He is a previous President of the British Cardiac Intervention Society and was previously the Divisional Director for Cardiology, Cardiothoracic and Vascular Surgery at the John Radcliffe University Hospital, Oxford.
Through his position at the John Radcliffe, and his own practice at Oxford’s The Manor Hospital, Professor Banning provides specialist regional services for coronary and valvular heart disease patients to an area of 1.2 million people. He implants TAVI valves for patients with aortic stenosis in more than 200 people a year and coronary stents in more than 250 people each year.
Professor Banning is pioneering research in his field and lectures and operates nationally and internationally. He has authored several books on coronary intervention and has over 450 PUBMED listed scientific papers to his name with an ‘H index’ of more than 80.
23 Minutes – A video showing the speed at which Adrian and his team respond to save lives.
Research Highlights
Development of new procedures and research have been a passion for Professor Banning since the mid 1990s. He has investigated the mechanisms of vascular injury following revascularisation, studying the long-term prognostic implications, which have redefined our understanding of revascularisation injury. He has studied how to optimise outcomes for patients presenting with heart attack and is a worldwide authority in this area.
Professor Banning was instrumental in the first clinical trials of drug eluting stents (DES) and he championed the use of intravascular ultrasound (IVUS) in the UK. This lead to his participation in landmark international interventional studies, such as TAXUS, Excel and Syntax. He was the co PI of the international Syntax 2 trial, which showed how stents can be used rather than surgery in most patients
Today, he continues to pioneer developments in Transcatheter Aortic Valve Implantation (TAVI) – an ultra-minimally invasive procedure.
